Transcat Stock Price, News & Analysis

Transcat Inc. (NASDAQ: TRNS), a provider of calibration services and professional test equipment, has announced its participation in the 22nd Annual Craig-Hallum Institutional Investor Conference. The event will take place on May 28, 2025, at the Depot Renaissance Hotel in Minneapolis, Minnesota.

The company's leadership team, including CEO Lee Rudow, CFO Tom Barbato, and COO Mike West, will be available for one-on-one and small group meetings with investors throughout the conference. Interested parties can schedule meetings through their Craig-Hallum representative or by contacting TRNS@mzgroup.us.

Transcat (Nasdaq: TRNS), a provider of calibration services and test equipment, has scheduled its fourth quarter fiscal year 2025 earnings release for Monday, May 19, 2025, after market close. The company will host a conference call and webcast on Tuesday, May 20, 2025, at 11:00 a.m. Eastern Time to discuss financial results and corporate strategy.

Investors can access the call via phone at (201) 689-8471 or through the webcast on Transcat's investor relations website. A replay will be available until May 27, 2025, by dialing (412) 317-6671 with conference ID 13753614, or through the company's website where a transcript will also be posted.

Transcat (NASDAQ: TRNS), a provider of calibration services and test equipment distribution, has engaged MZ Group for strategic investor relations services. The company reported strong financial performance with Q3 2025 revenue of $66.8 million and FY 2024 revenue growth of 13% to $259.5 million. Notable achievements include:

- 63 consecutive quarters of Service segment revenue growth - FY 2024 gross margin of 34% - FY 2024 Adjusted EBITDA of $38.6 million - Net income up 28% to $13.6 million - Operating free cash flow of $19.3 million - Low leverage ratio of 0.97 with $40.5 million available credit

The company's recent Martin Calibration acquisition strengthens its Midwest presence in life sciences and aerospace/defense markets. The global calibration services market is projected to reach $8.1 billion by 2030, driven by regulatory standards and increased manufacturing automation.

Transcat (NASDAQ: TRNS) reported its Q3 FY2025 financial results with consolidated revenue growing 2.4% to $66.8 million. The company experienced mixed performance across segments, with Distribution revenue increasing 6.5% to $25.2 million while Service revenue remained flat at $41.6 million.

Notable financial metrics include a decrease in gross profit by 6% to $19.7 million, with gross margin declining 260 basis points. Operating income dropped 51.1% to $2.1 million, and net income decreased 29.6% to $2.357 million. Adjusted EBITDA fell 13.2% to $7.9 million.

The company completed the acquisition of Martin Calibration, a significant addition with revenue exceeding $25 million. Service organic revenue was impacted by holiday timing, showing a 3.8% decrease. Management expects FY25 Service organic revenue growth in the mid-to-low single digits and anticipates a return to historical organic growth levels.

Transcat (Nasdaq: TRNS) has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its financial results after market close on Monday, January 27, 2025. A conference call and webcast to discuss the results and corporate strategy will be held on Tuesday, January 28, 2025, at 11:00 a.m. Eastern Time.

The conference call can be accessed via phone at (201) 689-8471, and a webcast with accompanying slides will be available on Transcat's investor relations website. A replay will be accessible until February 4, 2025, by dialing (412) 317-6671 with conference ID 13750934, or through the company's website where a transcript will also be posted.

Transcat (Nasdaq: TRNS) has acquired Martin Calibration Inc. for $79 million, comprising $69 million in cash and $10 million in company stock. Martin, an ISO-17025 Accredited calibration laboratory network with over $25 million in revenue, operates seven labs across the Midwest, including its flagship Minneapolis facility and locations in Chicago, Milwaukee, Eau Claire, Tempe, and Los Angeles.

The acquisition, Transcat's largest to date, strengthens its presence in the Medical, Life Science, Aerospace, and Nuclear sectors. Martin brings nearly 150 employees and 35 years of metrology expertise to Transcat's operations. The strategic move expands Transcat's geographic reach, particularly in the medical device and life science-rich Minneapolis region, while adding new capabilities and expertise to its service portfolio.

Transcat (NASDAQ: TRNS) reported Q2 fiscal 2025 results with consolidated revenue up 8% to $67.8 million. Service Revenue grew 6% to $44.1 million, marking the 62nd consecutive quarter of growth, while Distribution Revenue increased 11.1% to $23.7 million. Net income rose significantly to $3.3 million ($0.35 per diluted share) from $460,000 ($0.06 per diluted share) in the prior year. The company faced challenges with its Nexa business slowdown and hurricane impacts on Becnel operations, leading to a slight decline in gross margins. Management expects mid-single-digit organic Service revenue growth for FY25 and anticipates returning to high single-digit growth by first half of FY26.